Overall Technical outlook

Price Summary

On 2025-08-13, Jubilant Pharmova Limited's stock began at 1078.1, peaked at 1087.1, bottomed at 1065.2, and closed -0.06% down at 1077.5, with a volume of 132577 shares.
The peak price for the stock in the past 52 weeks is 1254.55, with the lowest price being 828.1.

Technicals

Support and Resistance: The current price is 1077.5, with support at 1002.55 and resistance at 1094.2. This range suggests that the price might move between these levels, with 1002.55 offering support and 1094.2 capping further gains for Jubilant Pharmova Limited.
JUBLPHARMA supportResistance 8d6392
Support/Resistance for JUBLPHARMA


Aroon: The Aroon indicator shows a continuation of the bearish trend, with Aroon Down holding steady at the 100 level. This ongoing downward pressure requires further exploration with additional indicators to understand its broader implications.
JUBLPHARMA aroon 8d6392
Aroon chart for Jubilant Pharmova Limited


Bol. Bands: The BOLL BANDS is currently neutral, showing no clear bias toward an upward or downward trend. This suggests that the market may be in a phase of indecision or consolidation.
JUBLPHARMA bbands 8d6392
Bolinger Bands chart for Jubilant Pharmova Limited


Parabolic SAR: The PSAR remains in a bearish mode, setting a strong resistance level that could impede any upward trends. This resistance indicates that the market may struggle to break higher, reflecting ongoing bearish sentiment for JUBLPHARMA.
JUBLPHARMA psar 8d6392
Parabolic Stop and Reverse chart for Jubilant Pharmova Limited


Stochastic: The Stochastic K-line, now below the D-line and under 20, signals a mildly bearish market outlook. This configuration suggests possible weakness for Jubilant Pharmova Limited, though the bearish sentiment is not overly pronounced. Investors should take note of this and monitor the trend closely.
JUBLPHARMA stoch 8d6392
Stochastic chart for Jubilant Pharmova Limited


Tripple Moving Agerage: The Tripple MOVING AVG is currently neutral, offering no clear guidance on market direction. This suggests that the market may be in a state of pause, with no strong trend emerging.
JUBLPHARMA trippleSMA 8d6392
Tripple SMA chart for Jubilant Pharmova Limited


When analyzing a company, its fundamentals—such as earnings, management efficiency, and strategic initiatives—must be considered alongside technical data. The context of the industry in which the company operates also plays a key role, as market trends and competitive dynamics can significantly impact performance. By taking a comprehensive approach, combining both fundamental and technical analysis, one can gain a deeper understanding of the company's potential for growth or risk.